Next, we assessed the ratio of CD44+CD24-/low cells, the subpopulation that have been demonstrated to adopt stem-like phenotypes and tumor-initiating potential (Shien et al., 2013; Chao et al., 2014). The gene discussed is CD24; the disease is neoplasm.